Compare AIT & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIT | ELAN |
|---|---|---|
| Founded | 1923 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.3B |
| IPO Year | N/A | 2018 |
| Metric | AIT | ELAN |
|---|---|---|
| Price | $258.10 | $21.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $291.00 | $21.13 |
| AVG Volume (30 Days) | 239.4K | ★ 4.8M |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | ★ 6.01 | N/A |
| EPS | ★ 10.39 | 0.07 |
| Revenue | ★ $4,664,003,000.00 | $4,591,000,000.00 |
| Revenue This Year | $7.57 | $7.19 |
| Revenue Next Year | $5.30 | $5.32 |
| P/E Ratio | ★ $24.82 | $302.26 |
| Revenue Growth | ★ 4.03 | 3.08 |
| 52 Week Low | $199.96 | $8.02 |
| 52 Week High | $280.95 | $23.70 |
| Indicator | AIT | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 48.37 |
| Support Level | $254.70 | $21.60 |
| Resistance Level | $262.92 | $23.70 |
| Average True Range (ATR) | 6.05 | 0.66 |
| MACD | 1.21 | -0.11 |
| Stochastic Oscillator | 79.26 | 34.18 |
Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.